The variable use of heparin through intravenous bolus and flush fluid systems during endovascular stroke treatment, a world-wide survey.

ABSTRACT:

Background

The total amount of heparin administered through flush fluids in stroke patients is not considered in recent trials, possibly influencing main results. We investigated the use of heparin among treating physicians worldwide.

Methods

We conducted a survey from November 2022 to January 2023 to identify the variability of heparin administration during stroke endovascular treatment (EVT). We calculated the total heparin dose per hour (IU/h) by adding the intravenous (IV)-bolus dose to the amount administered through flush fluids, calculated by a multiplication of the number of infusion bags, drip rate[mL/h] and heparin concentration[IU/L].

Results

A total of 315 participants from different countries worldwide completed the survey and 231/315(73%) respondents adm

SUBMITTER: Frol S 

PROVIDER: S-EPMC11872961 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature